|

pNGVL4aCRTE6E7L2 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 2

Top Sponsors

  • University of Alabama at Birmingham1
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Indications

  • Cancer2
  • Cervical Intraepithelial Neoplasia, Grade III1
  • Cervical Intraepithelial Neoplasia Grade II1
  • Human Papillomavirus Type 161
  • LSIL1

Birmingham, Alabama2 trials

HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

University of Alabama at Birmingham

Phase 1
Study of Treatment for HPV16+ ASC-US or LSIL

UAB | The University of Alabama at Birmingham

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.